Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052).
about
Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061A Comparison of South African National HIV Incidence Estimates: A Critical Appraisal of Different MethodsAntiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study.The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human bloodIncorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assayFailure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screeningAddressing standards of care in resource-limited settings.Low-level Viremia early in HIV infection.Infrequent HIV testing and late HIV diagnosis are common among a cohort of black men who have sex with men in 6 US cities.Plasmodium falciparum Infection Does Not Affect Human Immunodeficiency Virus Viral Load in Coinfected Rwandan Adults.Lack of Awareness of Human Immunodeficiency Virus (HIV) Infection: Problems and Solutions With Self-reported HIV Serostatus of Men Who Have Sex With MenPerformance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern AfricaPerformance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialPretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.Cascade of HIV care and population viral suppression in a high-burden region of Kenya.Antiretroviral Treatment and Sexual Risk Behavior in South Africa.Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial.Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection.Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention.Misdiagnosed HIV infection in pregnant women initiating universal ART in South Africa.Brief Report: Impact of Early Antiretroviral Therapy on the Performance of HIV Rapid Tests and HIV Incidence Assays.Evaluation of a Multidrug Assay for Monitoring Adherence to a Regimen for HIV Preexposure Prophylaxis in a Clinical Study, HIV Prevention Trials Network 073.Virologic outcomes in early antiretroviral treatment: HPTN 052.Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043).Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial.The validity of self-reported antiretroviral use in persons living with HIV: a population-based study.HIV-Positive Kidney Donor Selection for HIV-Positive Transplant Recipients.Hiv Drug Resistance in Adults Receiving Early Versus Delayed Antiretroviral Therapy: Hptn 052.
P2860
Q27312940-D55D0FF4-5430-457B-8133-3E8FF2A05524Q28546966-15893C9E-3638-43AD-9572-86F3A4B35454Q28550081-2700DE08-DA68-4DE4-92A0-774A3D29FF7CQ33647567-87043298-A86E-4EA9-AD21-8B346FE47274Q33690506-8BC00F01-1B0B-4045-9A39-5E75C3B6FB41Q33916829-1BCBD04F-B528-49B7-9BA2-ED2E63B48583Q34205686-208D40E4-4DE4-4FBC-8B5C-E719C8C1AB85Q34214090-73ABD67F-5E9D-4CEE-8E72-3231D42023E0Q34421897-6ED83903-275F-4E64-A84F-6ADAEA14C9A8Q34422229-2527A906-947A-434C-9E78-CBB80C8B83DCQ34801934-92134291-54F2-4605-A7D8-E8370CB04FF0Q34802147-1C0D6A95-A473-4653-B191-6872540CDA3FQ35056570-1879DC43-43CA-43FB-9B73-7186844C15C4Q35080053-F3C82011-2FD2-49CA-8AB6-97C7B661B410Q35124927-FD62E527-099E-417D-BFF3-A63161E29FCAQ35588149-CD7BEB09-A2CB-41D5-9D25-BD2CC55AFE9AQ35853796-DE4047B3-CE5F-4BE4-A026-AF1BD5D4D41EQ36487984-804B9A73-DABC-40D9-8F25-17D04F1F13C0Q36889651-5454CB40-132C-45DF-B06B-C631C3B898FFQ37014155-582AB270-0F0F-47EC-851F-F24A576A3EACQ37395586-2850182A-656C-463F-84C0-6597DDF0687BQ38850925-CB09E5E5-595B-4B21-BDEC-4CEE816A4B62Q40057840-E801FE17-2636-43E5-B683-42A61AB17C3DQ40226580-B463FD5F-D6F9-4B14-81A3-E9F0B30F4431Q40239354-A9D69783-F215-4924-A26D-C70EB536BBB3Q40254515-5B1E0A40-A78A-4735-B5CE-BAC40A8B113BQ40458433-0BE0BD00-3B60-4CBF-A384-CA409A7215FBQ40572857-EF16B622-3113-4A42-98A0-6BA1C5D5D53CQ47385522-EF0CDE56-122A-4665-9F9B-9C57D5699503Q47554143-4FE3689B-72BB-4514-B4B1-C090A3967008Q47559042-B82946BA-11E4-49E8-8043-7BE32D27F59F
P2860
Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Undisclosed antiretroviral dru ...... revention Trials Network 052).
@en
Undisclosed antiretroviral drug use in a multinational clinical trial
@nl
type
label
Undisclosed antiretroviral dru ...... revention Trials Network 052).
@en
Undisclosed antiretroviral drug use in a multinational clinical trial
@nl
prefLabel
Undisclosed antiretroviral dru ...... revention Trials Network 052).
@en
Undisclosed antiretroviral drug use in a multinational clinical trial
@nl
P2093
P2860
P50
P356
P1476
Undisclosed antiretroviral dru ...... revention Trials Network 052).
@en
P2093
Breno R Santos
Craig W Hendrix
James G Hakim
Jessica M Fogel
Johnstone Kumwenda
Jose Pilotto
Marybeth McCauley
Mina C Hosseinipour
Namandjé N Bumpus
P2860
P304
P356
10.1093/INFDIS/JIT390
P407
P50
P577
2013-08-01T00:00:00Z